Le tamoxifène en situation adjuvante dans le cancer du sein : trente ans d’expérience

R Buzzoni, L Biganzoli, E Bajetta, L Celio, A Fornasiero, L Mariani, N Zilembo, M Di Bartolomeo, A Di Leo, G Arcangeli, E Aitini, G Farina, G Schieppati, D Galluzzo, A Martinetti, Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer : a multicentre study by the ITMO group British Journal of Cancer. ,vol. 71, pp. 1111- 1114 ,(1995) , 10.1038/BJC.1995.215

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. The Lancet. ,vol. 359, pp. 2131- 2139 ,(2002) , 10.1016/S0140-6736(02)09088-8

Tamoxifen for early breast cancer: An overview of the randomised trials The Lancet. ,vol. 351, pp. 1451- 1467 ,(1998) , 10.1016/S0140-6736(97)11423-4

J. G.M. Klijn, R.W. Blamey, F. Boccardo, T. Tominaga, L. Duchateau, R. Sylvester, Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials Journal of Clinical Oncology. ,vol. 19, pp. 343- 353 ,(2001) , 10.1200/JCO.2001.19.2.343

Thierry Delozier, Marc Spielmann, Josette Macé-Lesec’h, Maud Janvier, Catherine Hill, Bernard Asselain, Jean-Pierre Julien, Béatrice Weber, Louis Mauriac, Jean-Christophe Petit, Pierre Kerbrat, Jean-Pierre Malhaire, Philippe Vennin, B. Leduc, Moïse Namer for the, , Tamoxifen Adjuvant Treatment Duration in Early Breast Cancer: Initial Results of a Randomized Study Comparing Short-Term Treatment With Long-Term Treatment Journal of Clinical Oncology. ,vol. 18, pp. 3507- 3512 ,(2000) , 10.1200/JCO.2000.18.20.3507

F. Boccardo, A. Rubagotti, A. Perrotta, D. Amoroso, M. Balestrero, A. De Matteis, P. Zola, P. Sismondi, G. Francini, R. Petrioli, M. Sassi, P. Pacini, E. Galligioni, Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study Annals of Oncology. ,vol. 5, pp. 337- 342 ,(1994) , 10.1093/OXFORDJOURNALS.ANNONC.A058837

C.D.B. Love, B. B. Muir, J. B. Scrimgeour, R. C.F. Leonard, P. Dillon, J. M. Dixon, Investigation of Endometrial Abnormalities in Asymptomatic Women Treated With Tamoxifen and an Evaluation of the Role of Endometrial Screening Journal of Clinical Oncology. ,vol. 17, pp. 2050- 2050 ,(1999) , 10.1200/JCO.1999.17.7.2050

Richard R. Love, Richard B. Mazess, Howard S. Barden, Sol Epstein, Polly A. Newcomb, V. Craig Jordan, Paul P. Carbone, David L. DeMets, Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer The New England Journal of Medicine. ,vol. 326, pp. 852- 856 ,(1992) , 10.1056/NEJM199203263261302

Thierry Delozier, Jean-Pierre Julien, Paul Juret, Corinne Veyret, Jean-Etienne Couëtte, Yvon Graic, Jean-Michel Ollivier, Edith de Ranieri, Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial. Breast Cancer Research and Treatment. ,vol. 7, pp. 105- 109 ,(1986) , 10.1007/BF01806795

H. J. Stewart, R. J. Prescott, A. P. M. Forrest, Scottish Adjuvant Tamoxifen Trial: a Randomized Study Updated to 15 Years Journal of the National Cancer Institute. ,vol. 93, pp. 456- 462 ,(2001) , 10.1093/JNCI/93.6.456